Impact of revised stage classification of lung cancer on survival: A military experience

Chest

Volumn 115, Issue 6, 1999, Pages 1507-1513

  Adebonojo, Samuel A ^a,c   Bowser, Andrew N ^a   Moritz, Dennis M ^b   Corcoran, Philip C ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Lung cancer; Lung cancer staging; Lung neoplasm; Surgery; Survival rate

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PACLITAXEL; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG LOBECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; PUBLIC HOSPITAL; SOLDIER; SURVIVAL RATE; SURVIVAL TIME;

EID: 0033033910     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.6.1507     Document Type: Article

References (18)

1. 1 Denoix PF. Enquete permanent das les centers anticanceras. Bull Inst Nat Hyg 1946; 1:70-75
2. 2 Mountain CF. A new international staging system for lung cancer. Chest 1986; 89(suppl):225S-233S
3. 3 Wanatabe Y, Shimizu J, Oda M, et al. Proposal regarding some deficiencies in the new international staging system for non-small cell lung cancer. Jpn J Clin Oncol 1991; 21:160-168
4. 4 Brundage MD, Mackillop WJ. Locally advanced non-small cell lung cancer: do we know the question? A survey of randomized trials from 1966-1993. J Clin Epidemiol 1996; 49:183-192
5. 5 Mountain CF. Revision in the international system for staging lung cancer. Chest 1997; 111:1710-1717
6. 6 Mountain CF, Dresler CM. Regional lymph node classification for lung cancer. Chest 1997; 111:1718-1723
7. 7 Inoue K, Sato M, Fujimura S, et al. Prognostic assessment of 1,310 patients with non-small cell lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg 1998; 116:407-411
8. 8 Kaplan EI, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53:457-481
9. 9 Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest 1997; 112:693-701
10. 10 Drings P, Bulzebruck H, Vogt-Moykopf I. Prognostic impact of the new 5th edition of the TNM classification for lung cancer (1997). Lung Cancer 1997; 18(suppl 1):215-230
11. 11 Faber LP. General thoracic surgery. J Am Coll Surg 1998; 186:162-172
12. 12 Nesbitt JC, Pitman JB, Walsh GL, et al. Survival in early stage non-small cell lung cancer. Ann Thorac Surg 1995; 60:466-472
13. 13 Ginsberg RJ, Vokes EE, Ruben A. Non-small cell lung cancer. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia, PA: Lippincott-Raven, 1997; 838-891
14. 14 Kim DH, Lynch TJ, Mentzer SJ, et al. Multimodality therapy of patients with stage IIIA, N2 non-small cell lung cancer: impact of preoperative chemotherapy and resectability and downstaging. J Thorac Cardiovasc Surg 1993; 106:696-708
15. 15 Ihde DC. Chemotherapy for lung cancer. N Engl J Med 1992; 327:1434-1441
16. 16 Martini N, Kris MG, Flehinger BJ, et al. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993; 55:1356-1374
17. 17 Weksler B, Bains M, Burt M, et al. Resection of lung cancer invading the diaphragm. J Thorac Cardiovasc Surg 1997; 114:500-501
18. 18 Margolis ML. Lung cancer staging: a proposal. Chest 1998; 114:661-662